During the Q1 of 2024, we generated $3,400,000 of revenue from the Blue Angels. Operating expenses for the 3 months ended March 31, 2024 were $15,100,000 including approximately $600,000 of depreciation and amortization and $1,800,000 of amortization of capitalized costs related to the Blue Angels, compared to $12,500,000 of operating expenses for the 3 months ended March 31, 2023, including approximately $500,000 of depreciation and amortization. Net loss for the quarter ended March 31, 2024 was approximately $300,000 and includes approximately $600,000 of depreciation and amortization and $1,800,000 of amortization of capitalized production costs related to the Blue Angels and $500,000 of interest expense. This compares to the net loss of $3,000,000 for the same period in 2023, which includes approximately $500,000 of depreciation and amortization, dollars 400,000 of interest expense and $100,000 of equity losses in unconsolidated affiliates. Loss per share was $0.02 per share based on 18,477,825 weighted average shares outstanding for basic loss per share and 18,605,702 weighted average shares per fully diluted loss per share for the 3 months ended March 31, 2024.